Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M300170-JLR200 on July 1, 2003

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M300170-JLR200v1
44/9/1790    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bojesen, I. N.
Right arrow Articles by Hansen, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bojesen, I. N.
Right arrow Articles by Hansen, H. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 44, 1790-1794, September 2003
Copyright © 2003 by American Society for Biochemistry and Molecular Biology

Binding of anandamide to bovine serum albumin

Inge N. Bojesen1,* and Harald S. Hansen{dagger}

* Department of Medical Biochemistry and Genetics, Lab. B., University of Copenhagen, The Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark
{dagger} Department of Pharmacology, The Danish University of Pharmaceutical Sciences, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark

Published, JLR Papers in Press, July 1, 2003. DOI 10.1194/jlr.M300170-JLR200

1 To whom correspondence should be addressed. e-mail: norby{at}imbg.ku.dk


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The endocannabinoid anandamide is of lipid nature and may thus bind to albumin in the vascular system, as do fatty acids. The knowledge of the free water-phase concentration of anandamide is essential for the investigations of its transfer from the binding protein to cellular membranes, because a water-phase shuttle of monomers mediates such transfers. We have used our method based upon the use of albumin-filled red cell ghosts as a dispersed biological "reference binder" to measure the water-phase concentrations of anandamide. These concentrations were measured in buffer (pH 7.3) in equilibrium with anandamide bound to BSA inside resealed human red cell membranes at low molar ratios below one. Data were obtained at 0°C, 10°C, 23°C, and 37°C. The equilibrium dissociation constant (Kd) increases with temperature from 6.87 ± 0.53 nM at 0°C to 54.92 ± 1.91 nM at 37°C. Regression analyses of the data suggest that BSA has one high-affinity binding site for anandamide at all four temperatures. The free energy of anandamide binding ({Delta}G0) is calculated to -43.05 kJ mol-1 with a large enthalpy ({Delta}H0) contribution of -42.09 kJ mol-1.

Anandamide has vasodilator activity, and the binding to albumin may mediate its transport in aqueous compartments.

Supplementary key words equilibrium dissociation constant • resealed red cell membranes • erythrocyte ghosts • equilibrium constant of anandamide-albumin complex • anandamide monomer concentration


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Anandamide and other N-acylethanolamines can be formed in many mammalian tissues (1), and anandamide is a partial agonist for the cannnabinoid receptors (2) and for the vanilloid receptor (3). Anandamide can be formed during tissue injury (1) and it can have pharmacological effects on the vascular system (4–6). Endocannabinoids appear to have a key vasodilator role in the hypotension associated with hemorrhagic, endotoxic, and cardiogenic shock as well as late-stage cirrhosis (6).

It can be presumed that anandamide normally will occur in biological fluid in very low concentrations, and owing to its hydrophobic character, it must be transported bound to protein. This presumption is verified by Giuffrida et al. (7), who found that anandamide is bound to a plasma protein identified as albumin. The concentration of anandamide in rat and human plasma is in the nM range [0.7–8 nM (7–9) and 4 nM (10), respectively]. This concentration is regarded as being too low for anandamide to act as a circulating active compound, insofar as the Ki for displacing synthetic radiolabeled ligands from the cannabinoid receptor I is in the range of 44 to 266 nM in the presence of a fatty acid amide-hydrolase inhibitor (11).

The concentration of albumin is ~640 µM (12) and 630 µM (13) in rat and human plasma, respectively. Thus, the molar ratio ({nu}) of anandamide to albumin in rat and human plasma is in the range of 1–10 x 10-6. Therefore, we have chosen to study the binding of anandamide to serum albumin at low {nu} values using the method developed for long-chain fatty acids (14). The equilibrium binding constant of anandamide to BSA has not been determined previously, but the binding of the corresponding fatty acid, arachidonic acid, has been studied (15). At {nu} values lower than 3, three equivalent binding sites were found with a equilibrium dissociation constant (Kd) value of 28 nM at 37°C (15). Recently, high-resolution crystal structures of human serum albumin (HSA) complexed with arachidonic acid have been presented. At high unphysiological {nu} values, as many as seven different sites for arachidonic acid are described (16). N-oleoylethanolamine has recently been shown to bind to HSA and BSA with high affinity (17), but binding of anandamide has not been reported.

The aim of the present study is to measure binding of anandamide to BSA and measure the free water-phase concentration of anandamide (Aw) using our method of studying binding of fatty acids to BSA (14, 15).


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Materials
Radioactive anandamide, N-arachidonoyl-[5,6,8,9,11,12,14,15-3H]ethanolamine, spec.act., 215 Ci/mmol, was obtained from Perkin-Elmer Life Sciences, Inc., Boston, MA, and unlabeled anandamide was purchased from BIOMOL Research Laboratories Inc., Plymouth Meeting, PA. Both labeled and unlabeled anandamide were purified before use by chromatography on a 160 x 0.8 mm column filled with Sephadex LH-20 using dichloromethane as eluant. The scintillation fluid was Ultima Gold from Packard Instrument Co., Inc., and BSA albumin fraction V (fatty acid free) was from Boehringer Mannheim GmbH, Germany.

Preparation of erythrocyte ghosts
The preparation of uniform populations of BSA-filled and BSA-free resealed red cell membranes ("pink" ghosts) from freshly drawn human blood was carried out as described previously (18). The ghosts were isolated from the hemolysate by centrifugation and washed at 0°C with 165 nM KCl, 2 mM phosphate buffer, pH 7.3, containing 0.02 mM EDTA-EGTA (1:1, v/v) (buffer I). They were stored in the same buffer containing BSA of appropriate concentrations and used for experiments within 2 days.

Preparation of incubation buffers
[3H]anandamide and unlabeled anandamide were dissolved in 50 µl benzene just enough to moisten 200 mg small glass beads (diameter 0.1 mm). The benzene was sublimated at low pressure, and incubation buffers were prepared by shaking the anandamide-loaded beads with buffer I containing BSA for 15 min at room temperature.

Determination of the dissociation equilibrium constants of anandamide binding to BSA
Human resealed red cell membranes have been used in a method originally developed for measuring the equilibrium constants of long-chain fatty acid binding to BSA (14, 15). BSA-filled ghosts were packed by centrifugation for 7 min at 30,000 g in a Sorval RC SC at the appropriate temperature and equilibrated with buffer I containing labeled as well as unlabeled anandamide bound to BSA (BSA-A) in different molar ratios of anandamide to BSA ({nu}). The water-phase concentrations were determined for anandamide Aw in equilibrium with BSA-A inside ghosts as a function of the {nu} of anandamide to total BSA as described by Bojesen and Bojesen (14, 15). In the {nu} values, Aw is neglected compared with the concentration of bound anandamide, because it is more than three orders of magnitude lower (see Discussion). The BSA-A inside ghosts are at equilibrium with anandamide in the membrane and with anandamide in the outer medium. Efflux data (unpublished) show that this equilibrium is obtained very quickly in accordance with the rapid free diffusion of anandamide across membranes seen by Glaser et al. (19).

Determinations were carried out at four different temperatures after equilibration for 50 min at 0°C, 30 min at 10°C, 20 min at 23°C, and 15 min at 37°C.

The definition of the Kd of anandamide dissociation from BSA is given in equation 1:

According to a model in which all binding sites on BSA are equivalent and independent (20), i.e., the sites have the same affinity for anandamide and the binding is noncooperative, we get (as shown in equation 2a, b):

which, linearized according to Wilkinson (21), gives

From this equation, Kd values and the number of binding sites on BSA (N) were estimated by linear regression analyses.

The equilibrium association constant of anandamide to BSA (Ka) is equal to 1/Kd.

Gibbs free energy of binding ({Delta}G0) was calculated as shown in equation 3:

where R is the gas constant and T is temperature in Kelvin. {Delta}H0 for the dissociation process was obtained from the slope (Fig. 2) after linear regression analysis of the van't Hoff equation: ln Kd/(1/T) = {Delta}H0/R. T{Delta}S0 was calculated as {Delta}G0-{Delta}H0.



View larger version (8K):
[in this window]
[in a new window]
  		Fig. 2. Van't Hoff plot of the temperature effect on the Kd values of anandamide. Each value is given with ± standard error; linear regression gives R = -0.999.

 
Scintillation counting
We used a Tri-Carb 2200CA liquid scintillation analyser from Hewlett-Packard. The efficiency was 67% for 3H in unquenched samples. Counting rates were determined, after the addition of 3.9 ml Ultima Gold scintillation fluid, to a probable error smaller than 1%. Aliquots of buffers after the equilibration of charge buffers with ghosts were taken for counting, and {nu} values were calculated from the counting rates (Ca) (dpm/ml) and the specific activities (S) (dpm/nmol) as Ca/(S [BSA]). Aws were determined from counting rates of duplicates of ghost-free supernatant (Cs) (dpm/ml) and S as Cs/S.

Statistics
Regression lines of Wilkinson plots and the statistics of slopes and intercepts were estimated by standard methods (22). Standard errors of estimated parameters of N and Kd values were calculated according to the general function given by Armitage (22), neglecting the unknown contribution of covariance. Weighted means of Kd values were calculated by giving single estimates the weights of the reciprocal variances of estimations (22).


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Kd s of N number of BSA binding sites
Aws in equilibrium with BSA have been determined. In order to be sure that no significant amount of anandamide was washed out from BSA during the procedure, we conducted a series of experiments with BSA-free as well as BSA-filled ghosts that were washed with 50 vol of BSA-free buffer I. No depletion of BSA-A inside ghosts took place.

Analyses of data obtained at 0°C, 10°C, 23°C, and 37°C were carried out after linearization of the relations between {nu} and Aw according to Wilkinson (equation 2). Figure 1A and B show examples of such plots. Table 1 shows corresponding measurement of Kd and N for anandamide at the four temperatures. The data clearly show that there is only one binding site on BSA for anandamide independent of temperature from 0°C to 37°C. In contrast, the Kd is temperature dependent. The values in column 5 are weighted mean values of Kd calculated for N = 1. From the temperature dependence of the equilibrium dissociation constants, it is possible to calculate values for the thermodynamic functions involved in the binding and dissociation process. In the calculation of {Delta}G0 according to equation 3, we have used Ka values calculated from Kd values normalized to N = 1. The free energy of anandamide binding ({Delta}G0) is calculated to -43.05 kJ mol-1 (range, 42.7–43.1 kJ mol-1). In Fig. 2 , data for the Kd values calculated for one binding site on BSA are plotted according to the van't Hoff equation. The linear correlation is good, and a binding enthalpy ({Delta}H0) of -42.09 kJ mol-1 was obtained from the slope.



View larger version (9K):
[in this window]
[in a new window]
  		Fig. 1. Examples of plots to determine equilibrium dissociation constants (Kds) and number of binding sites (N) according to equation 2b. A: Anandamide data at 10°C, pH 7.3. The regression line is Y = 1.02 (± 0.05) X + 9.97 (± 0.64), R = 0.99. The insert shows the structural formula of anandamide. B: Anandamide data at 37°C, pH 7.3. The regression line is Y = 1.34 (± 0.13) X + 50.28 (± 2.11), R = 0.95.

 

View this table:
[in this window]
[in a new window]
  		TABLE 1. Estimation by regression analyses according to Wilkinson (21) of the number of binding sites (N, mean ± SEM) on BSA for anandamide, and equilibrium dissociation constants (Kd s, mean ± SEM) of anandamide-BSA complexes at different temperatures

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
BSA as well as HSA is able to bind a variety of hydrophobic compounds, among others, fatty acids. The architecture of such proteins is best described by their interactions with fatty acids. The most important approach to studying such interactions is the use of NMR spectroscopy and X-ray crystallography. NMR is a powerful tool for the study of microenvironments of sites in specific domains. In fatty acid-BSA interactions, three primary binding sites are found for physiological {nu} values lower than three. At these sites, there are two kinds of interactions, hydrophobic and electrostatic. In the first, the alkyl chain interacts with hydrophobic amino acid residues, whereas in the second, the carboxyl group interacts with basic amino acid residues (23–26). At higher {nu} values, sites with lower affinity appear with less-defined interactions between the carboxyl group and basic amino acid residues.

X-ray diffraction studies are consistent with NMR data but are carried out mainly with HSA, which is very similar to BSA. The first crystallographic analyses revealed that the protein contains three homologous domains and that each domain is a product of two subdomains able to bind fatty acids (27, 28). Later, precise locations of up to seven fatty acid binding sites were reported and each site was described in detail (16, 29). However, very high unphysiological {nu} values were used in these studies. For HSA complexed with 12 myristic molecules, six binding sites were observed. Five of these appear to have electrostatic interactions with basic amino acid residues, and the methylene tails were accommodated within hydrophobic cavities (29). The last site has less-well-defined interactions at the carboxyl group.

Anandamide differs from the fatty acids insofar as it is a neutral molecule, and in the present paper, we find that for {nu} values lower than 1, anandamide binds to BSA in only one high-affinity binding site, with a somewhat lower binding constant than seen for arachidonic acid and the other long-chain fatty acids studied (30). The finding of only one binding site is quite interesting; we had expected three binding sites, as seen for arachidonic acid. This means that BSA must bind the neutral anandamide differently, as compared with a hydrophobic anion such as arachidonic acid. Perhaps the binding of anandamide is favored in one of the above-mentioned sites in which the electrostatic interactions are less well defined. It is also important to note that not only is anandamide a neutral molecule but it is also much larger than arachidonic acid. In this respect it is interesting that BSA has only one binding site for the very long chain fatty acid, hexacosanoic acid (26:0) (31). However, a complete and reliable assignment of the anandamide binding site on BSA is unsettled and will require further work.

Zolese et al. (17) have studied the binding of N-oleylethanolamine to BSA . Fluorescence data disclosed that N-oleylethanolamine binds not only to hydrophobic sites near tryptophan-212 in BSA but also at other binding sites affecting the environment of tryptophan-134. However, their averaged Kd (21 µM) is orders of magnitude higher than that determined for anandamide in this study. A binding site for oleic acid has also been found in the N terminal part of BSA. After proteolytic fragmentation of the BSA molecule, a single distinct NMR resonance peak is seen after the addition of 1 mol oleic acid to the fragment, which consists of amino acid residues 1–306 (25). The site is defined as a primary (high-affinity) site, but whether this site is the same as that defined by Zolese et al. is unsettled.

The thermodynamic analyses show that the binding energy is mainly enthalpic in both anandamide and arachidonic acid. Arachidonic acid has a carboxyl group, but anandamide has an amide bond as well as a hydroxyl group. Therefore anandamide is a less-hydrophobic molecule than arachidonic acid. This is confirmed by the lower entropy contribution to the free energy of binding (Table 2). Or, in other words, in solution, the water is much more structured around a hydrophobic molecule, which means that the transfer of arachidonic acid from water to BSA will result in an entropy contribution that is higher than in the case of anandamide. A difference of a factor of 10 is seen (Table 2). Furthermore, anandamide has more possibilities to form hydrogen bonds than does arachidonic acid, which possibly explains the more negative {Delta}H0 (Table 2) for the transfer from water to BSA.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Thermodynamic parameters for binding of arachidonic acid and anandamide to BSA

 
A very high percentage of plasma anandamide is bound to albumin (>99%). With a concentration of total anandamide in human plasma of 4 nM and an albumin concentration of 630 µM, the normal {nu} value is 0.63 x 10-5, which gives a free water-phase concentration of 3.5 x 10-13 M (according to equation 2a) and a free-to-bound ratio of anandamide of ~0.01%. Although the aqueous concentration of anandamide is very low, a fast dissociation from albumin will allow equilibrium to binding sites on cells. A fast dissociation from albumin can be deduced from the rapid uptake of anandamide by cells from albumin-bound anandamide (19).

One aspect of the importance of the results obtained in the present paper is probably that knowing the values of Kd and N, one is able to calculate the water-phase concentration of anandamide according to equation 2a at all {nu} lower than one. The knowledge of such concentrations is helpful for studying effects and binding of anandamide to membranes and receptors, as well as for understanding the physiological functions of anandamide.


   ACKNOWLEDGMENTS
 
This study was supported by grants from the Danish Medical Research Council, Novo Nordisk Foundation, and Carlsberg Foundation. The technical assistance of Aase Frederiksen is gratefully acknowledged.

Manuscript received April 24, 2003 and in revised form June 18, 2003.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Hansen, H. S., B. Moesgaard, H. H. Hansen, and G. Petersen. 2000. N-acylethanolamines and precursor phospholipids—relation to cell injury. Chem. Phys. Lipids. 108: 135–150.[CrossRef][Medline]

  2. Howlett, A. C., F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, R. Mechoulam, and R. G. Pertwee. 2002. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54: 161–202.[Abstract/Free Full Text]

  3. Di Marzo, V., P. M. Blumberg, and A. Szallasi. 2002. Endovanilloid signaling in pain. Curr. Opin. Neurobiol. 12: 372–379.[CrossRef][Medline]

  4. Randall, M. D., D. Harris, D. A. Kendall, and V. Ralevic. 2002. Cardiovascular effects of cannabinoids. Pharmacol. Ther. 95: 191–202.[CrossRef][Medline]

  5. Kunos, G., Z. Járai, S. Bátkai, S. K. Goparaju, E. J. N. Ishac, J. Liu, L. Wang, and J. A. Wagner. 2000. Endocannabinoids as cardiovascular modulators. Chem. Phys. Lipids. 108: 159–168.[CrossRef][Medline]

  6. Kunos, G., S. Bátkai, L. Offertáler, F. Mo, J. Liu, J. Karcher, and J. Harvey-White. 2002. The quest for a vascular endothelial cannabinoid receptor. Chem. Phys. Lipids. 121: 45–56.[CrossRef][Medline]

  7. Giuffrida, A., F. Rodriguez de Fonseca, F. Nava, P. Loubet-Lescoulié, and D. Piomelli. 2000. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur. J. Pharmacol. 408: 161–168.[CrossRef][Medline]

  8. Giuffrida, A., and D. Piomelli. 1998. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett. 422: 373–376.[CrossRef][Medline]

  9. Burstein, S. H., S. M. Huang, T. J. Petros, R. G. Rossetti, J. M. Walker, and R. B. Zurier. 2002. Regulation of anandamide tissue levels by N-arachidonylglycine. Biochem. Pharmacol. 64: 1147–1150.[CrossRef][Medline]

  10. Wang, Y., Y. Liu, Y. Ito, T. Hashiguchi, I. Kitajima, M. Yamakuchi, H. Shimizu, S. Matsuo, H. Imaizumi, and I. Maruyama. 2001. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal. Biochem. 294: 73–82.[CrossRef][Medline]

  11. Pertwee, R. G. 1997. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74: 129–180.[CrossRef][Medline]

  12. Habgood, M. D., J. E. C. Sedgwick, K. M. Dziegielewska, and N. R. Saunders. 1992. A developmentally regulated blood-cerebrospinal fluid transfer mechanism for albumin in immature rats. J. Physiol. 456: 181–192.[Abstract/Free Full Text]

  13. Peters, T., Jr. 1996. All About Albumin. Biochemistry, Genetics and Medical Applications. Academic Press, San Diego. 256–260.

  14. Bojesen, I. N., and E. Bojesen. 1992. Water-phase palmitate concentrations in equilibrium with albumin-bound palmitate in a biological system. J. Lipid Res. 33: 1327–1334.[Abstract]

  15. Bojesen, I. N., and E. Bojesen. 1994. Binding of arachidonate and oleate to bovine serum albumin. J. Lipid Res. 35: 770–778.[Abstract]

  16. Petitpas, I., T. Grune, A. A. Bhattacharya, and S. Curry. 2001. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 314: 955–960.[CrossRef][Medline]

  17. Zolese, G., G. Falcioni, E. Bertoli, R. Galeazzi, M. Wozniak, Z. Wypych, E. Gratton, and A. Ambrosini. 2000. Steady-state and time resolved fluorescence of albumins interacting with N-oleylethanolamine, a component of the endogenous N-acylethanolamines. Proteins. 40: 39–48.[CrossRef][Medline]

  18. Bojesen, I. N., and E. Bojesen. 1991. Palmitate binding to and efflux kinetics from human erythrocyte ghost. Biochim. Biophys. Acta. 1064: 297–307.[Medline]

  19. Glaser, S. T., N. A. Abumrad, F. Fatade, M. Kaczocha, K. M. Studholme, and D. G. Deutsch. 2003. Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. USA. 100: 4269–4274.[Abstract/Free Full Text]

  20. van Holde, K. E., W. C. Johnson, and P. S. Ho. 1998. Principles of Physical Biochemistry. Prentice Hall, New Jersey.

  21. Wilkinson, G. N. 1961. Statistical estimations in enzyme kinetics. Biochem. J. 80: 324–332.[Medline]

  22. Armitage, P. 1971. Statistical Methods in Medical Research. Blackwell Scientific Publications, Oxford. 97, 98, 197.

  23. Cistola, D. P., D. M. Small, and J. A. Hamilton. 1987. Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. II. Electrostatic interactions in individual fatty acid binding sites. J. Biol. Chem. 262: 10980–10985.[Abstract/Free Full Text]

  24. Cistola, D. P., D. M. Small, and J. A. Hamilton. 1987. Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. I. The filling of individual fatty acid binding sites. J. Biol. Chem. 262: 10971–10979.[Abstract/Free Full Text]

  25. Hamilton, J. A., S. Era, S. P. Bhamidipati, and R. Reed. 1991. Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc. Natl. Acad. Sci. USA. 88: 2051–2054.[Abstract/Free Full Text]

  26. Hamilton, J. A. 2002. How fatty acids bind to proteins: the inside story from protein structures. Prostaglandins Leukot. Essent. Fatty Acids. 67: 65–72.[CrossRef][Medline]

  27. Carter, D. C., and J. X. Ho. 1994. Structure of serum albumin. Adv. Protein Chem. 45: 153–203.[Medline]

  28. He, X. M., and D. C. Carter. 1992. Atomic structure and chemistry of human serum albumin. Nature. 358: 209–215.[CrossRef][Medline]

  29. Curry, S., P. Brick, and N. P. Franks. 1999. Fatty acid binding to human serum albumin: new insights from crystallographic studies. Biochim. Biophys. Acta. 1441: 131–140.[Medline]

  30. Bojesen, I. N., and E. Bojesen. 1996. Albumin binding of long-chain fatty acids: thermodynamics and kinetics. J. Phys. Chem. B. 100: 17981–17985.[CrossRef]

  31. Choi, J. K., J. Ho, S. Curry, D. H. Qin, R. Bittman, and J. A. Hamilton. 2002. Interactions of very long chain saturated fatty acids with serum albumin. J. Lipid Res. 43: 1000–1010.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. DeMorrow, H. Francis, E. Gaudio, J. Venter, A. Franchitto, S. Kopriva, P. Onori, R. Mancinelli, G. Frampton, M. Coufal, et al.
The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway
Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1150 - G1158.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
W. Xiong, M. Hosoi, B.-N. Koo, and L. Zhang
Anandamide Inhibition of 5-HT3A Receptors Varies with Receptor Density and Desensitization
Mol. Pharmacol., February 1, 2008; 73(2): 314 - 322.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. E. Spivak, C. R. Lupica, and M. Oz
The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Kaczocha, A. Hermann, S. T. Glaser, I. N. Bojesen, and D. G. Deutsch
Anandamide Uptake Is Consistent with Rate-limited Diffusion and Is Regulated by the Degree of Its Hydrolysis by Fatty Acid Amide Hydrolase
J. Biol. Chem., April 7, 2006; 281(14): 9066 - 9075.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
I. N. Bojesen and H. S. Hansen
Effect of an unstirred layer on the membrane permeability of anandamide
J. Lipid Res., March 1, 2006; 47(3): 561 - 570.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
I. N. Bojesen and H. S. Hansen
Membrane transport of anandamide through resealed human red blood cell membranes
J. Lipid Res., August 1, 2005; 46(8): 1652 - 1659.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M300170-JLR200v1
44/9/1790    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bojesen, I. N.
Right arrow Articles by Hansen, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bojesen, I. N.
Right arrow Articles by Hansen, H. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Advertisement
spacer
Advertisement
Advertisement